• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Fingolimod (marketed as Gilenya) Information

An oral medication for the treatment of relapsing forms of Multiple Sclerosis (MS) in adults.  Used to reduce the frequency of flare-ups (clinical exacerbations) and delay physical disability.


Labeling and Regulatory History from Drugs@FDA


Contact FDA

1-800-FDA-0178 Fax
Report a Serious Problem

MedWatch Online

Regular Mail: Use postage-paid FDA Form 3500

Mail to: MedWatch 5600 Fishers Lane

Rockville, MD 20857